Market News

GRDN stock: attractive assisted-living pharmacy growth and scale advantages, but ~32x forward P/E limits upside and safety.

The URB offering — a high-performing solution for folding cartons, laminations, edge protectors, tubes and cores, and other specialty purposes — posit...

B of A Securities analyst Ken Hoexter upgrades Saia (NASDAQ:SAIA) from Neutral to Buy and raises the price target from $499 to $502.

BTIG analyst Peter Saleh reiterates Wingstop (NASDAQ:WING) with a Buy and maintains $305 price target.

Repurchases to begin following the filing of the Company's Form 10-Q for the second quarter of 2026Babcock & Wilcox Enterprises, Inc. (NYSE:BW...

Parcel Pending by Quadient Open Locker Network in the UK The Parcel Pending by Quadient locker network now exceeds 3,000 locations across the UK. The ...

SK hynix (SKHY) initiated Buy with $300 ADR target. Learn why its HBM leadership, NVIDIA/TSMC ties, and AI demand could drive upside—read now.

Lockheed Martin faces execution risks but gains from rising defense demand; see 2026 guidance, new missile contracts, valuation, and what to do now.

HC Wainwright & Co. analyst Raghuram Selvaraju maintains BridgeBio Pharma (NASDAQ:BBIO) with a Buy and raises the price target from $110 to $12...

The new variant is expected to sit above the Model Y L, making it Tesla’s priciest Model Y in China.

https://www.bloomberg.com/news/articles/2026-07-13/uae-tweaks-offshore-oil-pricing-to-support-non-hormuz-options

Salesforce is hoping its acquisition of Fin can help accelerate revenue growth.

FTSE 100 up 1 point at 10,498 Oil prices hit 3-week high amid new US-Iran strikes Plus500, PageGroup, Oxford Nanopore post numbers 5.15pm: Investors c...

According to a CNBC report, UBS has reiterated its ‘Buy’ rating on Bloom Energy and currently has a price target of $350 on BE stock.

Micron stock dips 5% premarket as tech stocks face profit-taking. Is MU's long-term uptrend still intact? Get the technical analysis.

US stocks closed higher on Friday with the Dow Jones gaining 150 points. S&P 500 and Nasdaq also rose. Analyst ratings can be used as trading indi...

Truist Securities analyst Srikripa Devarakonda upgrades Biogen (NASDAQ:BIIB) from Hold to Buy and raises the price target from $190 to $235.

Stitch Fix (SFIX) rebound case: Q3 customer growth, higher margins, raised guidance, and deep-value valuation with debt-free balance sheet—read now.

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates CervoMed (NASDAQ:CRVO) with a Buy and maintains $25 price target.

Bitcoin, gold, and silver have different long-run fundamentals. Over the past two months, however, they have traded off the same short-run macro impul...